Aprea Therapeutics, Inc. (APRE) vs Bolt Biotherapeutics, Inc. (BOLT)
A side-by-side comparison of Aprea Therapeutics, Inc. and Bolt Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APRE
Aprea Therapeutics, Inc.
$0.68HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BOLT
Bolt Biotherapeutics, Inc.
$3.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APRE vs BOLT
growth of $100 · dividends reinvested · last 6yAPRE -99.5% (-58.5%/yr)BOLT -99.5% (-58.1%/yr)BOLT compounded faster over this window
APRE BOLT
APRE vs BOLT: by the numbers
- •APRE is the larger company ($8M vs $7M market cap).
- •Both run net losses; APRE's is the smaller (0.00% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | APRE | BOLT |
|---|---|---|
| P/S ratio | N/A | 1.43 |
| P/B ratio | 0.22 | 0.53 |
Profitability
| Metric | APRE | BOLT |
|---|---|---|
| Gross margin | 0.00% | 80.62% |
| Operating margin | 0.00% | -450.07% |
| Net margin | 0.00% | -611.47% |
| ROE | -31.99% | -227.37% |
| ROIC | -33.73% | -90.17% |
Growth (annualized)
| Metric | APRE | BOLT |
|---|---|---|
| Total return CAGR (5Y) | -63.30% | -57.61% |
Frequently asked
- How have APRE and BOLT total returns compared?
- Over the past 5 years, APRE delivered -63.30% and BOLT delivered -57.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.